Characterization of myelin-associated glycoprotein (MAG) proteolysis in the human central nervous system.
Purified human central nervous system myelin contains an endogenous cysteine protease which degrades the 100-kDa myelin-associated glycoprotein into a slightly smaller 90-kDa derivative called dMAG, and which has been implicated in demyelinating diseases. The native proteolytic site in human MAG was determined in order to characterize this cysteine protease in humans further. This was accomplished by identifying the carboxy-terminus of purified dMAG. The results of these experiments, in conjunction with peptidolysis assays of myelin, demonstrated that the enzyme which proteolyses MAG is extracellular and has cathepsin L-like specificity. Furthermore, it was shown that this cathepsin L-like activity potentially was regulated by the endogenous extracellular inhibitor cystatin C.
Stebbins
J W
JW
Demyelinating Disorders Unit, LMCN, NINDS, NIH, Bethesda, MD 20892, USA. stebbins@helix.nih.gov
Jaffe
H
H
Möller
J R
JR
D000595:Amino Acid Sequence; D001921:Brain / Q000378:metabolism*; D056668:Cathepsin L; D002403:Cathepsins / Q000378:metabolism; D003546:Cysteine Endopeptidases; D010450:Endopeptidases; D006801:Humans; D006868:Hydrolysis; D013058:Mass Spectrometry; D008969:Molecular Sequence Data; D009186:Myelin Sheath / Q000201:enzymology / Q000378:metabolism; D018992:Myelin-Associated Glycoprotein / Q000737:chemistry / Q000378:metabolism*
D018992:Myelin-Associated Glycoprotein; D002403:Cathepsins; D010450:Endopeptidases; D003546:Cysteine Endopeptidases; C534281:CTSL protein, human; D056668:Cathepsin L